-+ 0.00%
-+ 0.00%
-+ 0.00%

ENDRA Life Sciences Q1 EPS $(1.09) Beats $(1.14) Estimate

Benzinga·05/18/2026 12:04:37
Listen to the news
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(1.09) per share which beat the analyst consensus estimate of $(1.14) by 4.39 percent. This is a 41.4 percent increase over losses of $(1.86) per share from the same period last year.